Detalhe da pesquisa
1.
A combination of cyclophosphamide and interleukin-2 allows CD4+ T cells converted to Tregs to control scurfy syndrome.
Blood;
137(17): 2326-2336, 2021 04 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33545713
2.
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway.
J Allergy Clin Immunol;
149(2): 550-556.e2, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34800432
3.
Donor-targeted serotherapy as a rescue therapy for steroid-resistant acute GVHD after HLA-mismatched kidney transplantation.
Am J Transplant;
20(8): 2243-2253, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32065452
4.
Complement C5 inhibition in patients with COVID-19 - a promising target?
Haematologica;
105(12): 2847-2850, 2020 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33256385
5.
Exome-First Strategy in Adult Patients With CKD: A Cohort Study.
Kidney Int Rep;
8(3): 596-605, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36938085
6.
Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy.
Front Immunol;
12: 680567, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34248962
7.
Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.
Nat Commun;
12(1): 6446, 2021 11 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34750385
8.
Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study.
EClinicalMedicine;
28: 100590, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33173853